Abstract:As one typical intratumoral nanosynthetic medicine (INSM), in situ biosynthesized supramolecular self-assemblies point at the accurate transformation of disordered small molecules into stable, morphology-defined and function-specific polymers by tumor microenvironment (TME) stimuli-unlocked intermolecular forces at objective locations. This artificially-manipulated spatiotemporal synthesis strategy is one main direction of current biomedical development. Aiming at the aberrant microenvironment, precisely and controllably constructing theranostic nano-sized self-assemblies with highly sensitive and specific responses to special TME or trigger at the target location of tumor is highly emphasized and regarded as a great breakthrough in biomedicine. This technology is expected to provide new ideas for the artificially controllable self-assembly of small molecule nanomaterials into dynamic smart nanomedicines in living cells and permit to improve the delivery and retention of current self-assembly systems. This review summarized the recent progress and rationales of intratumoral stimuli-responsive in situ assembly of supramolecular self-assemblies based on artificial small molecule nanomaterials in tumors, and clarified how and why these TME triggers can trigger artificial small molecule to self-assembles. Moreover, the tumor-related stimulatory response components were discussed and the intermolecular driving forces or interactions after TME-triggered precursor cleavage were summarized, wherein the unique design concepts and the corresponding application innovation in the field of tumor diagnosis and treatment were clearly shed light on using some classic examples. Ultimately, the prospects, challenges that the intratumoral stimuli-responsive supramolecular self-assembly synthesis faced, and the potential solutions were put forward to deepen the understanding of future biomedical application and clinical translation.

Tumor microenvironment-triggered intratumoral in situ construction of theranostic supramolecular self-assembly

Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment

Tumor microenvironment-triggered intratumoral in-situ biosynthesis of inorganic nanomaterials for precise tumor diagnostics

Tumour Microenvironment-Responsive Semiconducting Polymer-Based Self-Assembling Nanotheranostics

Tumor-responsive Dynamic Nanoassemblies for Targeted Imaging, Therapy and Microenvironment Manipulation.

In Situ Stimulus-responsive Self-assembled Nanomaterials for Drug Delivery and Disease Treatment

In situ self-assembly for cancer therapy and imaging

Tumor Microenvironment–Responsive Peptide-Based Supramolecular Drug Delivery System

Cancer‐Selective Supramolecular Chemotherapy by Disassembly‐Assembly Approach

Tumor-Specific Formation Of Enzyme-Instructed Supramolecular Self-Assemblies As Cancer Theranostics

Self-Assembly of Small Organic Molecules into Luminophores for Cancer Theranostic Applications

Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy

Metal‐Coordinated Supramolecular Self‐Assemblies for Cancer Theranostics

Tumor Microenvironment Stimuli-Responsive Macrophage Cell Membrane-Decorated Multi-Functional Self-Assembled Gold-Quantum Dots Nanomaterials for Tumor Theranostic

Stimuli-activatable nanomedicine meets cancer theranostics

The Intracellular and Extracellular Microenvironment of Tumor Site: the Trigger of Stimuli‐Responsive Drug Delivery Systems

Endogenous Stimuli-Responsive DNA Nanostructures Toward Cancer Theranostics

Tumor microenvironment-responsive dynamic inorganic nanoassemblies for cancer imaging and treatment

Tacmaa Chemistry-Based Tumor Extracellular Ph-Responsive Polymeric Nanomaterials For Drug Delivery

Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems

Biopolymer-based tumor microenvironment-responsive nanomedicine for targeted cancer therapy